Skip to main content

STARLITE

STARLITE for Unresectable High-Grade Gliomas

  • RegistryNCT06428045
  • PhasePhase 1
  • StatusRecruiting
  • ConditionHigh Grade Glioma
  • SponsorUniversity of Miami
How STARLITE worksNCT064280451 min

What the film says

Read the transcript

This trial is for newly diagnosed high grade glioma, a brain tumor, that cannot be removed surgically, in adults.

The idea: combine heat and antiretroviral drugs. After a needle biopsy, MRI guided laser therapy heats the tumor. A week later, patients start combination antiretroviral therapy, with the ritonavir dose raised or lowered to find the best dose.

This phase 1 study plans 24 patients and first looks at dose limiting toxicity. At the University of Miami, Ashish Shah and Macarena De La Fuente lead it.

Public record; not medical advice.

Sources behind this film

  • ClinicalTrials.gov record NCT06428045

    Newly diagnosed high grade glioma that cannot be removed surgically, adults; After a needle biopsy, MRI guided laser therapy; A week later, combination antiretroviral therapy; ritonavir dose raised or lowered; Phase 1, 24 patients, dose limiting toxicity first (+1 more lines)

The drug

What is being tested.

Participants will take one 600mg tablet of Abacavir orally once daily, as part of combination antiretroviral therapy (ART).

Participants will take one 300mg tablet of Lamivudine orally once daily, as part of combination antiretroviral therapy (ART)

The study

How the trial runs.

The purpose of this study is to determine whether newly diagnosed high-grade glioma(s) that cannot be removed surgically change as a result of the study treatment; and to identify and evaluate the potential side effects (good and bad) of the study treatment in patients with newly diagnosed high-grade glioma(s) that cannot be removed surgically.

Live record on ClinicalTrials.gov →

Eligibility

Who the study is looking for.

  • Patients with a histologically confirmed or suspected high-grade glioma (HGG) by MRI.
  • a. For cases with suspected HGG, intraoperative frozen section diagnoses of HGG must be made by pathologists (Section 4.4.1).
  • Uni-focal or butterfly gliomas that can receive ≥70% of lesion volume ablated as determined by the treating surgeon.
  • Gliomas must be located or positioned where surgical resection is either not feasible or high-risk as deemed by a group of surgical neuro-oncologists.
  • Preoperative Karnofsky score ≥ 70 (APPENDIX A).
  • Patients must have demonstrable normal organ function as defined below within 14 days of surgery.

Inclusion criteria as written on the registry, trimmed. The full list, with exclusions, is on the live record.

For you, or someone you love

Whether or not this trial is the one, bring AI into your corner.

A complex diagnosis brings new questions every week, in a trial and out of one. Triangle keeps your whole medical file together, reads it with you in plain language, and helps you and your family decide what to ask next.

Start your 7-day free trial

Then $9 a month. Cancel anytime.

  • Every record in one place

    Requested from your hospitals and clinics through the national networks. Add scans, pathology and anything on paper.

  • Read in plain words

    Reports explained as they come in, with lab values you can follow before treatment, during a trial and after.

  • Ready for every appointment

    Ask about your own file, and walk in with questions for your oncologist or the trial team.

  • Your people, in the loop

    Share one profile with the family helping you, and with your doctors.

Members also get a deeper analysis of their records and any sequencing data, including clinical trials that may fit, reviewed by a licensed physician before they receive it.

Already in a trial?

It turns into a project to manage: visits, scans, labs, side effects and paperwork. Triangle keeps it organized in one place for you or for whoever's helping.

Organize my trial

7-day free trial, then $9 a month. Cancel anytime.

How these trials work: what Phase 1 actually is · common questions Not clinical evidence.